Electromed Inc Quick Ratio (ELMD) starting from the fourth quarter 2026 to fourth quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Electromed Inc   (NYSEAMER: ELMD)

Electromed Inc 's Quick Ratio

ELMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Electromed Inc 's Cash & cash equivalent grew by 20.4 % in the Q4 2026 sequentially, while Current Liabilities decreased, this led to improvement in Electromed Inc 's Quick Ratio to 2.35, above Electromed Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 75 other companies have achieved higher Quick Ratio than Electromed Inc in fourth quarter 2026. While Quick Ratio total ranking has improved so far during the Q4 2026 to 1287, from total ranking in the third quarter 2026 at 1312.

Explain Quick Ratio?
How much Cash & cash equivalents ELMD´s has?
What are ELMD´s Current Liabilities?




ELMD Quick Ratio (Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
(Jun 30 2025)
Q4
Y / Y Current Liabilities Change -16.76 % 20.15 % 36.36 % 18.06 % 95.63 %
Y / Y Cash & cash equivalent Change 33.77 % 11.47 % -4.93 % 1.8 % -4.93 %
Quick Ratio MRQ 2.35 1.66 1.46 1.61 1.46
ELMD's Total Ranking # 1287 # 1312 # 950 # 956 # 1172
Seq. Current Liabilities Change -14.79 % -2.31 % 19.51 % -16.33 % 22.99 %
Seq. Cash & cash equivalent Change 20.4 % 11.11 % 8.32 % -7.68 % 0.33 %



Quick Ratio fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 464
Overall Market # 1287


Quick Ratio Statistics
High Average Low
4.51 1.67 0.12
(Jun 30 2020)   (Mar 31 2013)




Financial Statements
Electromed Inc 's Current Liabilities $ 9 Millions Visit ELMD's Balance sheet
Electromed Inc 's Cash & cash equivalent $ 20 Millions Visit ELMD's Balance sheet
Source of ELMD's Sales Visit ELMD's Sales by Geography


Cumulative Electromed Inc 's Quick Ratio

ELMD's Quick Ratio for the trailling 12 Months

ELMD Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 12.01 % 37.86 % 42.7 % 30.45 % 33.6 %
Y / Y Cash & cash equivalent TTM Growth 10.53 % 0.67 % 3.79 % 23.84 % 43.33 %
Quick Ratio TTM 1.75 1.54 1.57 1.71 1.77
Total Ranking TTM # 3857 # 3113 # 2460 # 2949 # 3035
Seq. Current Liabilities TTM Growth -4.39 % 4.49 % 7.88 % 3.93 % 17.67 %
Seq. Cash & cash equivalent TTM Growth 8.37 % 2.92 % -1.31 % 0.41 % -1.29 %


On the trailing twelve months basis ELMD Cash & cash equivalent grew by 33.77 % in Q4 2026 year on year, while Current Liabilities fell to $9 millions, this led to increase in in Electromed Inc 's Quick Ratio to 1.75, above ELMD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Electromed Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 3113 to 3857.

Explain Quick Ratio?
How much Cash & cash equivalents ELMD´s has?
What are ELMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 885
Within the Market # 3857


trailing twelve months Quick Ratio Statistics
High Average Low
3.25 1.57 0.24
(Mar 31 2021)   (Dec 31 2013)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions

Date modified: 2026-09-08T15:22:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.